The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients

Prostate-specific antigen (PSA) is currently the most useful biomarker for detection of prostate cancer (PCa). The ability to measure serum PSA levels has affected all aspects of PCa management over the past two decades. The standard initial systemic therapy for advanced PCa is androgen-deprivation...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Takeshi, Sugimura, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306761/
https://www.ncbi.nlm.nih.gov/pubmed/30567361
http://dx.doi.org/10.3390/jcm7120565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306761/
https://www.ncbi.nlm.nih.gov/pubmed/30567361
http://dx.doi.org/10.3390/jcm7120565

Ejemplares similares